Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06160323

Upfront EUS CGN/CPN vs Conventional Step up Approach for Inoperable Painful Pancreatic Cancer

Led by Chinese University of Hong Kong · Updated on 2026-05-06

94

Participants Needed

1

Research Sites

246 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Patients with unresectable pancreatic cancer are often demoralized by intractable, persistent and incapacitating pain. It must be managed aggressively and strong opioids are recommended as the mainstay of treatment. However, patients develop opioid-related adverse effects. EUS-guided celiac plexus neurolysis (CPN) and celiac ganglion neurolysis (CGN) has been shown to provide high efficacy for pain control. The optimal timing, however, is in debate.

CONDITIONS

Official Title

Upfront EUS CGN/CPN vs Conventional Step up Approach for Inoperable Painful Pancreatic Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age �3 18 years old
  • Diagnosed to have inoperable pancreatic cancer
  • Presence of tumor pain (centrally located, constant, with no other obvious cause) with a VAS �3 3
  • Karnofsky performance status �3 60
  • Planned for EUS examination and/or biopsy of the pancreatic tumor
Not Eligible

You will not qualify if you...

  • Allergy to bupivacaine or alcohol
  • Potentially operable after neoadjuvant therapy
  • Expected survival of less than 3 months
  • Already on opioids for pain control
  • Previous percutaneous or EUS-guided CGN/CPN
  • Recurrent pancreatic tumors after operation
  • Uncorrectable coagulopathy
  • Inability or unwillingness to provide informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Prince of Wales Hospital

Hong Kong, Hong Kong, Hong Kong, 00000

Actively Recruiting

Loading map...

Research Team

S

Shannon Melissa Chan

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Upfront EUS CGN/CPN vs Conventional Step up Approach for Inoperable Painful Pancreatic Cancer | DecenTrialz